| Factor | Category/increment | Change in AMD severity score (n = 820) | Progression to CNV (n = 95) | Progression to CGA (n = 64) | B | 95% CI | value | B | 95% CI | value | B | 95% CI | value |
| Age | 1 year | 0.005 | −0.013, 0.023 | 0.574 | 0.058 | 0.008, 0.108 | 0.023 | 0.056 | −0.008, 0.120 | 0.087 | Sex | Female vs. male | −0.053 | −0.201, 0.095 | 0.486 | 0.116 | −0.288, 0.521 | 0.573 | 0.019 | −0.439, 0.477 | 0.935 |
| Smoking status | Never | Ref | | | Ref | | | Ref | | | Former | 0.138 | −0.044, 0.319 | 0.137 | 0.344 | −0.128, 0.816 | 0.154 | 0.175 | −0.440, 0.790 | 0.577 | Current | 0.289 | −0.044, 0.622 | 0.089 | 0.558 | −0.202, 1.319 | 0.150 | 0.962 | 0.114, 1.811 | 0.026 | Cilioretinal artery | Present vs. absent | −0.089 | −0.272, 0.094 | 0.339 | −0.157 | −0.684, 0.370 | 0.370 | −0.083 | −0.730, 0.563 | 0.801 | CRAE | 1 mm | 0.001 | −0.003, 0.006 | 0.527 | −0.007 | −0.019, 0.006 | 0.280 | −0.002 | −0.019, 0.015 | 0.795 | CRVE | 1 mm | 0.003 | −0.002, 0.007 | 0.288 | −0.003 | −0.016, 0.010 | 0.685 | 0.004 | −0.011, 0.020 | 0.576 | AVR | — | 0.049 | −1.409, 1.506 | 0.948 | −2.350 | −6.443, 1.742 | 0.260 | −1.991 | −7.799, 3.817 | 0.502 |
|
|
AMD, age-related macular degeneration; CNV, choroidal neovascularization; CGA, central geographic atrophy; B, beta coefficient; CI, confidence interval; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent; AVR, arteriole-to-venule ratio.
|